Oncology Background information for medical media outside the US only This selection gives an overview on background material for Oncology available on the Boehringer Ingelheim corporate website.

Press Releases

• 22 October 2008Boehringer Ingelheim broadens oncology pipeline with promising new data for potentially first in class Plk1 inhibito
• 25 April 2008Data suggests promising overall survival and progression-free survival with Vargatef™ (BIBF 1120)
• 14 February 2008FDA grants fast track designation for Boehringer Ingelheim's BIBW 2992 for the treatment of late stage non small cell lung cancer (NSCLC)
• 07 September 2007Ablynx and Boehringer Ingelheim announce major global strategic alliance to discover, develop and commercialise novel nanobody® therapeutics
• press release archive

Documents

• Fact sheet: Research Areas Research Institute of Molecular Pathology (IMP) - PDF (1.37 MB)
• Boehringer Ingelheim in Oncology - PDF (1.4 MB)
• Changing the face of cancer - PDF (960 KB)
• Media bulletin: Boehringer Ingelheim Oncology Progress Report - PDF (141 KB)
• Annual Report 2007: Page 65 - PDF (4.9 MB)